Cargando…

Prospective Evaluation of Health Care Provider and Patient Assessments in Chemotherapy-Induced Peripheral Neurotoxicity

BACKGROUND AND OBJECTIVE: There is no agreement on the gold standard for detection and grading of chemotherapy-induced peripheral neurotoxicity (CIPN) in clinical trials. The objective is to perform an observational prospective study to assess and compare patient-based and physician-based methods fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alberti, Paola, Bernasconi, Davide P., Cornblath, David R., Merkies, Ingemar S.J., Park, Susanna B., Velasco, Roser, Bruna, Jordi, Psimaras, Dimitri, Koeppen, Susanne, Pace, Andrea, Dorsey, Susan G., Argyriou, Andreas A., Kalofonos, Haralabos P., Briani, Chiara, Schenone, Angelo, Faber, Catharina G., Mazzeo, Anna, Grisold, Wolfgang, Valsecchi, MariaGrazia, Cavaletti, Guido
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10365895/ https://www.ncbi.nlm.nih.gov/pubmed/34078718 http://dx.doi.org/10.1212/WNL.0000000000012300

Ejemplares similares

Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Trial
por: Bruna, Jordi, et al.
Publicado: (2017)

Axonal degeneration in chemotherapy-induced peripheral neurotoxicity: clinical and experimental evidence
por: Park, Susanna B, et al.
Publicado: (2023)

Neurological Complications of Conventional and Novel Anticancer Treatments
por: Alberti, Paola, et al.
Publicado: (2022)

Promises and hurdles of undergraduate medical development in Greece
por: Ifanti, Amalia A, et al.
Publicado: (2011)

Na(V)1.7: Stress-induced changes in immunoreactivity within magnocellular neurosecretory neurons of the supraoptic nucleus
por: Black, Joel A, et al.
Publicado: (2013)

Chemotherapy-induced peripheral neuropathy in adults: a comprehensive update of the literature
por: Argyriou, Andreas A, et al.
Publicado: (2014)

Predictive Biomarkers of Oxaliplatin-Induced Peripheral Neurotoxicity
por: Velasco, Roser, et al.
Publicado: (2021)

Rasch analysis to evaluate the motor function measure for patients with facioscapulohumeral muscular dystrophy
por: Mul, Karlien, et al.
Publicado: (2020)

Cannabinoids: an Effective Treatment for Chemotherapy-Induced Peripheral Neurotoxicity?
por: Cavaletti, Guido, et al.
Publicado: (2021)

Sodium channel Nav1.7 in vascular myocytes, endothelium, and innervating axons in human skin
por: Rice, Frank L, et al.
Publicado: (2015)

A painful neuropathy-associated Nav1.7 mutant leads to time-dependent degeneration of small-diameter axons associated with intracellular Ca(2+) dysregulation and decrease in ATP levels
por: Rolyan, Harshvardhan, et al.
Publicado: (2016)

Reconstructing the Rasch-Built Myotonic Dystrophy Type 1 Activity and Participation Scale
por: Hermans, Mieke C. E., et al.
Publicado: (2015)

A randomised, multi‐centre phase III study of 3 different doses of intravenous immunoglobulin 10% in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ProCID trial): Study design and protocol
por: Cornblath, David R., et al.
Publicado: (2018)

Updates on Oxaliplatin-Induced Peripheral Neurotoxicity (OXAIPN)
por: Argyriou, Andreas A.
Publicado: (2015)

Skin biopsy and small fibre neuropathies: facts and thoughts 30 years later
por: Lauria, Giuseppe, et al.
Publicado: (2022)

Efficacy, safety, and tolerability of lacosamide in patients with gain-of-function Na(v)1.7 mutation-related small fiber neuropathy: study protocol of a randomized controlled trial–the LENSS study
por: de Greef, Bianca T. A., et al.
Publicado: (2016)

Intravenous immunoglobulin therapy for small fiber neuropathy: study protocol for a randomized controlled trial
por: de Greef, Bianca T. A., et al.
Publicado: (2016)

Self-Reported Assessment of the Socio-Economic Impact of Anticancer Chemotherapy-Related Neurotoxicity
por: Cavaletti, Guido, et al.
Publicado: (2023)

Intravenous Immunoglobulin Therapy in Patients With Painful Idiopathic Small Fiber Neuropathy
por: Geerts, Margot, et al.
Publicado: (2021)

Pain triangle phenomenon in possible association with SCN9A: A case report
por: Sopacua, Maurice, et al.
Publicado: (2022)

The applicability of the digit wrinkle scan to quantify sympathetic nerve function
por: Sopacua, Maurice, et al.
Publicado: (2022)

HDACi: The Columbus’ Egg in Improving Cancer Treatment and Reducing Neurotoxicity?
por: Squarzoni, Angelica, et al.
Publicado: (2022)

High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats
por: Meregalli, Cristina, et al.
Publicado: (2018)

Structural and functional cardiac changes in myotonic dystrophy type 1: a cardiovascular magnetic resonance study
por: Hermans, Mieke CE, et al.
Publicado: (2012)

Psychometric Properties of the Quantitative Myasthenia Gravis Score and the Myasthenia Gravis Composite Scale
por: Barnett, Carolina, et al.
Publicado: (2015)

Randomized trial of three IVIg doses for treating chronic inflammatory demyelinating polyneuropathy
por: Cornblath, David R, et al.
Publicado: (2022)

Safety and Tolerability of Intravenous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy: Results of the ProCID Study
por: Cornblath, David R., et al.
Publicado: (2023)

Identification of novel human receptor activator of nuclear factor-kB isoforms generated through alternative splicing: implications in breast cancer cell survival and migration
por: Papanastasiou, Anastasios D, et al.
Publicado: (2012)

Correction to: Identification of novel human RANK isoforms generated through alternative splicing. Implications in breast cancer cell survival and migration
por: Papanastasiou, Anastasios D., et al.
Publicado: (2018)

Iris Metastasis in a Patient With Small Cell Lung Cancer: A Case Report
por: Sakellakis, Minas, et al.
Publicado: (2016)

Pharmacogenetics in Model-Based Optimization of Bevacizumab Therapy for Metastatic Colorectal Cancer
por: Papachristos, Apostolos, et al.
Publicado: (2020)

Intra- and interfamily phenotypic diversity in pain syndromes associated with a gain-of-function variant of Na(V)1.7
por: Estacion, Mark, et al.
Publicado: (2011)

Taxane-Induced Peripheral Neurotoxicity
por: Velasco, Roser, et al.
Publicado: (2015)

Ethoxyquin provides neuroprotection against cisplatin-induced neurotoxicity
por: Zhu, Jing, et al.
Publicado: (2016)

Neuropathic Pain due to Small Fiber Neuropathy in Aging: Current Management and Future Prospects
por: Brouwer, Brigitte A., et al.
Publicado: (2015)

A gain-of-function sodium channel β2-subunit mutation in painful diabetic neuropathy
por: Alsaloum, Matthew, et al.
Publicado: (2019)

Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy: Results from the pre‐randomization phase of the Polyneuropathy And Treatment with Hizentra study
por: Mielke, Orell, et al.
Publicado: (2019)

Inhibition of NHE1 transport activity and gene transcription in DRG neurons in oxaliplatin-induced painful peripheral neurotoxicity
por: Dionisi, Marianna, et al.
Publicado: (2023)

Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights
por: Marmiroli, Paola, et al.
Publicado: (2017)

Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity
por: Meregalli, Cristina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jc4plpiejvvfe0t2t4ndg6okjr